Compare AUPH & KOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUPH | KOS |
|---|---|---|
| Founded | 1993 | 2003 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2014 | 2011 |
| Metric | AUPH | KOS |
|---|---|---|
| Price | $14.25 | $2.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $17.25 | $1.91 |
| AVG Volume (30 Days) | 1.1M | ★ 31.7M |
| Earning Date | 05-11-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | ★ 2.07 | N/A |
| Revenue | $283,055,000.00 | ★ $1,288,352,000.00 |
| Revenue This Year | $16.53 | $21.14 |
| Revenue Next Year | $16.24 | N/A |
| P/E Ratio | $7.06 | ★ N/A |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $6.83 | $0.84 |
| 52 Week High | $16.54 | $3.01 |
| Indicator | AUPH | KOS |
|---|---|---|
| Relative Strength Index (RSI) | 49.28 | 61.86 |
| Support Level | $13.52 | $1.64 |
| Resistance Level | $15.23 | $2.89 |
| Average True Range (ATR) | 0.45 | 0.21 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 36.73 | 82.11 |
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.